Tag Archives: delta variant

Health and Lifestyle, Local

Omicron COVID Variant Keeps Evolving, Transmission Rates Increasing in Washington

[OLYMPIA, Wash.] – (MTN) Using the Centers for Disease Control and Prevention’s (CDC) updated criteria for measuring the impact of COVID in a region, 15 Washington counties currently have high community levels of COVID-19. In March, the CDC changed the criteria for defining low, medium, and high to a formula that evaluates new cases, new hospital admissions, and the percent of in-patient staffed beds treating COVID-infected patients.

The University of Washington Virology Lab reported on Monday that test positivity was 15.4% from an Independence Day holiday reduced sample set. The rapidly evolving Omicron variant of COVID has eliminated the tidal waves of new cases that came in spikes every four to six months to a steady but controllable flood.

On November 28, 2021, the first Omicron cases were detected in Washington. A series of superspreader events over the weekend of December 4 in southwestern Washington spread new Omicron cases to 14 counties in less than ten days. By mid-January, Washington hospitals were on the precipice of moving to crisis standards of care.

The Omicron BA.2 variant was detected at the end of January and less than two months later had replaced the original Omicron strain accounting for 84% of new cases. However, on June 12, BA.2 was down to 17% of new cases. The BA.2 variant was replaced with the highly transmissible vaccine and prior immunity resistant BA.2.12 strain, which is already being replaced by BA.5.

Omicron BA.5 is a very vaccine and prior infection immunity resistant variant with similar genetic mutations to the Delta strain. The original vaccines remain effective at preventing hospitalization and severe illness but are offering diminished protection from catching COVID. Prior COVID infections, even from Omicron strains, provide little immunity to the new strains, especially BA.5.

Although the number of people infected by COVID is increasing, the number of deaths remains low due to many people’s broad baseline immunity. Researchers are still trying to understand the impact of long-COVID, defined as experiencing COVID systems or COVID-related complications more than 21 days after infection. It is estimated that 20% to 33% of people infected by coronavirus experience long-COVID. Symptoms can range from “COVID toe,” the loss of taste and smell, to debilitating migraines, joint pain, and fatigue.

Fifteen counties in Washington are feeling the sting from high community transmission of coronavirus, new hospital admissions, and the percentage of hospitalized patients with COVID. Asotin, Chelan, Clallam, Columbia, Douglas, Ferry, Grant, Grays Harbor, Lewis, Lincoln, Pacific, Pierce, Spokane, Thurston, and Walla Walla Counties have been advised to take increased protective measures, including wearing masks indoors.

King County didn’t make the list, but 4,900 people are being tested for COVID daily, and 20.2% of those tests return positive. The figure is artificially high compared to last year when home testing wasn’t widely available, and international travel required a negative PCR test. Additionally, many employers require repeated negative PCR tests in some job fields. Today, most PCR tests are only given to people suspected of having symptomatic COVID and to frontline healthcare workers with recent close exposure.

More troublesome is daily new hospital admissions for COVID cases have climbed to 25 a day in King County, a 54% increase from last week. Hospitalizations are a lagging indicator, spiking two to four weeks after a new case surge.

Many area hospitals are once again at or over capacity. A combination of acute staffing shortages, a return to everyday life, increasing accidents and work-related injuries, and hundreds of patients who can’t be released from the hospital because there aren’t enough transitional and long-term care facilities, has created a perfect storm. The bump in new COVID cases is adding to the problem.

COVID transmission remains low in outdoor, open-air settings. A driver of the increasing number of new COVID cases and hospitalizations has been the region’s cool and wet non-existent spring, keeping people indoors and windows closed. Even with the first days of summer here, the high temperature in Seattle struggled to reach 58 degrees on July 3rd.

While BA.5 is on track to become the next dominant strain in Washington, a new strain is already taking over on the other side of the planet. Omicron BA 2.75 was sequenced in India and is rapidly spreading across the region.

Health and Lifestyle, Local

Washington ending the statewide outdoor mask mandate as COVID cases and hospitalizations decline

[OLYMPIA, Wash.] – (MTN) Governor Jay Inslee announced that the outdoor mask mandate would end on Feb. 18 and that it is, “no longer a matter of if, but when,” for the end of the indoor mandate.

The outdoor mask mandate was implemented on Sept. 13, as hospitalizations for the delta variant peaked in Washington. The requirement applied to large outdoor events with 500 or more people. Enforcement of the outdoor mask requirement was close to non-existent, with Lumen Field full of maskless fans through the fall and early winter, cheering for the Seattle Seahawks.

Data has shown that COVID transmission rates are significantly lower in outdoor settings and areas with excellent air circulation.

The statewide indoor mask mandate, that was brought back on Aug. 19 still stands. Gov. Inslee said that he was taking a wait-and-see approach, and would revisit ending the indoor mask mandate as early as next week. California, Illinois, New York, and Oregon have ended or announced they are ending indoor mask mandates this week.

Washington repealed almost all COVID restrictions on Jun. 30 as hospitals emptied of COVID patients and the statewide vaccination rate for residents 16 and over approached 70%. Less than two months later the state was facing record hospitalizations due to the more transmissible and virulent Delta variant, just as school was restarting.

Washington never fully exited the delta wave when the first omicron case was detected on Nov. 29. More than a half-dozen high school wrestling matches on Dec. 4 in Pierce and Thurston Counties became super spreader events. New cases of omicron exploded from the Canada border to the Columbia River flooding Western Washington hospitals during the last week of December. The combination of holiday travelers and lower vaccination rates in Eastern Washington created a secondary wave in January.

New COVID cases are declining across the state and hospitalizations have peaked on both sides of the Cascades. Despite the improvement, there are still over 1,700 COVID patients in Washington hospitals according to the Washington State Hospital Association.

With the hospital situation improving, the statewide pause of “non-urgent” surgical procedures announced last month, will come to an end on Feb. 17. When Gov. Inslee announced the 28-day pause on Jan. 20, many hospitals had already taken the extraordinary measure independently.

At the peak of the omicron wave, Washington medical facilities were brought to the brink of collapse. The darkest days were during the week of Jan. 16. In an unprecedented move during the COVID pandemic, a handful of patients were transferred by aircraft out of Western Washington to Eastern Washington and Montana hospitals. On Jan. 19, the demand for hospital beds was outstripping all available resources.

To avoid moving the state to crisis standards of care, the Washington Medical Coordination Center (WMCC) implemented a protocol called guaranteed-acceptance hospital rotation. During guaranteed-acceptance hospital rotation, larger regional hospitals took turns taking accepting transfer patients and finding some way to care for them. By Jan. 23, the peak of the crisis had passed, and the protocol was ended.

The WMCC, which operates out of Harborview Medical Center, provides assistance to hospitals that need to move patients when the institution has exhausted all other options.

In Idaho, new COVID cases peaked earlier this week with test positivity reaching 34%. Southern Idaho has been operating under crisis standards of care for almost a month, and some patients from the Boise area have been arriving in Eastern Washington hospitals. Historically Alaska, Idaho, Eastern Oregon, and Western Montana have relied on Washington hospitals to take in critically ill patients and specialized cases.

The positivity rate for COVID tests in Washington has dropped to 18%, according to the University of Washington Virology Lab. So-called stealth omicron has been detected in Washington, but there has not been an increase in cases.

Virologists believe that between the statewide vaccination rate and how transmissible the Omicron variant is, many residents have some degree of immunity. The United States Centers for Disease Control is not supportive of repealing mask mandates because nationally new case rates remain extremely high, with over 110,000 hospitalized COVID patients.

Health and Lifestyle, Local, National

There is no such thing as Flurona or Deltacron

[KIRKLAND, Wash.] – (MTN) A review of the genetic information shared on GISAID by researchers in Cyprus, who claimed to have discovered a new COVID strain created by the antigenic shift between the Delta and Omicron variants, appears to be inaccurate.

Multiple virologists and scientists have reviewed the shared data and universally agree that the “variant” is not an antigenic shift, by a chimera likely caused by testing patients who were co-infected with Delta and Omicron. The story was broken by Bloomberg on Saturday and picked up by multiple news outlets including CNBC and Forbes.

Dr. Tom Peacock, a virologist with the Imperial College of London, explained in a Twitter thread that recombinations of tests samples are common and that this wasn’t caused by poor quality control in the lab or bad science.

Dr Leontios Kostrikis, the head of the University of Cyprus’ biotechnology and molecular virology lab, announced to reporters on Saturday his findings and shared them in the GISAID database. By Sunday both Bloomberg, who broke the story, and Dr Kostrikis were on the defensive insisting this was an antigenic shift.

In an e-mail, Dr Kostrikis wrote to Bloomberg that his findings “indicate an evolutionary pressure to an ancestral strain to acquire these mutations and not a result of a single recombination event.”

A study published on Oct. 14 called Genome Recombination between Delta and Alpha Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), explored recombination versus antigenic shift, and the need for due diligence before declaring a new variant has been identified. The study examined seven reports of the Alpha and Delta strain recombinations and found that when the lineages were traced, the combination of the two into a new and unique virus, antigenic shift, did not occur.

The study concluded, “we must intensively monitor and carefully inspect such marked genetic variations to ensure their proper characterization.”

The hype around “deltacron,” mirrors a similar scare around “flurona.” Headlines announced the findings of people co-infected with Influenza and COVID, which people misinterpreted as a new virus. Although Influenza and COVID are both viruses, the similarity ends there. Creating a new virus through an antigenic shift between the two would be like trying to breed a cougar with an elephant.

A meta-analysis published on Jun. 25, 2021, found almost one percent of confirmed COVID cases were among people co-infected with Influenza from December 2019 to September 2020.

Doctors and immunologists have explained that co-infection between multiple variants is possible, as is co-infection with Influenza or RSV. It is also possible for a coinfected person to spawn a new COVID variant if they were coinfected with two different strains at the same time. It appears in Cyprus, this isn’t the case.

Dr. Todd Wolynn, CEO of Kids Plus Pediatrics in Pittsburgh and an expert on medical misinformation and disinformation, explained why the headlines move faster than the science. “Before social media there use to be a saying, if it bleeds, it leads,” he said.

“Now with social media, if it scares it’s shared.”

On Friday the New York Times reported there were more than 900,000 confirmed COVID cases reported in the United States, representing a single-day record that would not include weekend or holiday data. Despite continued reports of the Omicron variant being mild, the United States also reached an alarming milestone, setting a new hospitalization record – 138,051 with 17,000 new hospitalizations because or with COVID a day.

Officials believe new COVID cases will peak in King County during the next seven to ten days. The IHME forecasts new coronavirus cases will peak at 38,000 on Feb. 4 in Washington. On Saturday the Washington State Department of Health reported 10,000 residents have died of COVID since Feb. 29, 2020.

Health and Lifestyle, Local, National

Record number of new COVID cases in Washington as hospitalizations climb

[OLYMPIA, Wash.] – (MTN) The Washington State Department of Health reported that the rate of new COVID cases exploded to 541.9 per 100,000 residents on Monday. The same report showed that coronavirus-related hospitalizations increased 49 percent in a week, from 736 on Dec. 26 to 1,099 on Jan. 2.

Several factors impacted today’s report, which may not show the true impact of COVID in Washington. Most tests sites were closed on New Year’s Day across the state, and numerous Western Washington test locations were closed on Dec. 30, 31, and Jan. 2 due to weather, power issues at one location, and insufficient staff. The hospitalization data appeared incomplete to the Malcontent News research team and will likely be updated tomorrow with more data.

A staggering 26 counties have extreme transmission, with another eight experiencing high transmission. Pierce County has the highest case rate in Washington, 771.0 per 100,000 people.

In King County, 25 people on average are hospitalized a day with COVID, breaking the previous record set during the Delta wave in September. Through Dec. 30, hospitalizations are up 81 percent, and the new case rate of 685.1 has never been higher.

The IHME forecasts hospitalizations will peak in early February, and COVID-related deaths will peak in March.

It wasn’t all bad news in the report. The number of Washingtonians who have received booster shots increased significantly from last week. There is strong evidence from multiple studies and hospitalization data from Israel, Europe, and the United Kingdom, that a third booster dose provides robust protection from severe COVID.

In welcome news to many parents, the United States Food and Drug Administration (FDA) authorized booster shots for 12 to 15-year-olds today and shortened the waiting period for the age group from six months after the second dose to five.

On Sunday, Dr. Anthony Fauci indicated that the United States Centers for Disease Control (CDC) was reconsidering new isolation and quarantine guidelines based on feedback. The CDC has faced withering criticism from healthcare providers and frontline workers for cutting quarantine time in half and relying on the honor system for those who are infected by asymptomatic.

Although Omicron has become the dominant strain in the United States, data out of Connecticut and Washington indicates it won’t squeeze Delta out. Complicating treatment and mitigation, ten percent of COVID cases continue to be Delta or so-called Delta Plus.

According to the New York Times, the United States recorded 1,003,043 new COVID cases on Monday, shattering all previous records. The 7 day moving average is approaching 500,000 new cases a day, which Malcontent News believes is a red line for United States hospitals.

There are now 102,479 people hospitalized with COVID, an increase of 41% from a week ago. Daily new hospital admissions now exceed all previous waves, except the first one, which peaked on Jan. 9, 2021. The United States will set a new all-time hospitalization record if the rate of increase remains unchanged during the coming week.

Testing resources in the United States are stretched to the breaking point, with laboratories processing a near-record number of tests daily. Monday night, the Georgia Department of Health tweeted they could not provide an updated COVID report because there is so much data.

University of Washington Medicine (UWM) officially takes over testing sites from King County on Tuesday. UWM announced that they would no longer provide prophylaxis COVID testing for work and travel, reserving resources only for people who are symptomatic or had close contact with someone infected with the coronavirus.

Speculation on how severe the Omicron variant is compared to Delta continues to run rampant. Disease acquired immunity, vaccinations, boosters, and demographic differences between nations have made reaching a concrete conclusion difficult. There is growing evidence that for the vaccinated, especially with boosters, the Omicron variant is mild to moderate for most.

For the unvaccinated, the data is less conclusive. In South Africa, hundreds have died in the last two weeks. While hospitalizations appear to have peaked, the number has remained almost unchanged for a week while the number of ICU patients and those requiring ventilators has grown. A study published by the United Kingdom Health Security Agency tracked 815 hospitalized Omicron patients with a median age of 45.5. The report found that 57 people had died in the group – seven percent. The ages of those who died ranged from 41 to 99.

Health and Lifestyle, Local, National

In 48 hours, COVID hospitalizations increased 13% in Washington

[OLYMPIA, Wash.] – (MTN) Washington hospitals added 92 more COVID patients between Monday and Wednesday, eliminating two weeks of improvement in 48 hours as new COVID cases rose to early November levels.

According to the Washington State Department of Health (WSDoH), there were 610 hospitalized COVID patients on Dec 20. That number rose to 702 on Wednesday. The number of patients on ventilators had dropped as low as 79 on Dec, 16, and had increased to 95 on Wednesday. Statewide 91% of staffed acute care, and 88% of staffed ICU beds were filled.

The Washington State Department of Health (WSDoH) also reported a sharp increase in new COVID cases. In a week the 7 day moving average increased 86% from 84.1 to 156.3 per 100K residents. Nine of the ten counties with the highest case rates are west of the Cascades, fueled in part by multiple super spreader events at schools in Pierce and Thurston Counties in early December.

Percent of Total Population Fully VaccinatedPercentage of Vaccinated People with Booster DoseTotal Population in GroupAverage 7-Day New Case Rate
70.00% or above39.15%2,343,250210.7
60.00% to 69.99%35.36%1,669,300162.6
50.00% to 59.99%32.23%3,339,300124.5
40.00% to 49.99%29.41%268,97577.9
32.70% to 39.99%35.38%151,85080.6
7 Day New Covid-19 Cases per 100K average by Vaccination Rate for Total Population, Adjusted for Population by County, Booster percentage is based on totally fully vaccinated, not eligible, Average 7-day New Case Rate <25 normal, =>25 to 99.9 moderate to significant, => 100, high transmission

The Puget Sound region had some of the highest new case rates in the state. Pierce County was in second place with 225.6 per 100K, King County was in fourth place with 213.6 per 100K, and Snohomish County was in eighth place reporting 144.6 cases per 100K residents. Twenty-four Washington counties have substantial or high transmission.

The University of Washington Virology Lab and Trevor Bedford, Ph.D. of Fred Hutch, estimate the Rt in King County is 4.4. Rt, or “r naught,” is a measurement for how quickly a disease is spreading within a population. The figure is an estimation of how many people an infected person will pass a disease to. In King County, a person infected with the Omicron variant is passing it to 4.4 people. In comparison, the highest rate experienced after March 2020 was 2.1 during the Delta wave.

In a series of tweets today, Bedford estimated that the time it takes to become symptomatic is shorter than the original strain and Delta, about three days, which may be contributing to the meteoric rise in cases and what may be a near equally fast decline.

Understanding how much Omicron can spread and how sick it is making people remains somewhat of a mystery. When COVID first struck in December 2019, it was moving through a population with no prior exposure, without vaccines, and no understanding of what an effective treatment plan looks like. Two years later hundreds of millions globally who have had prior infections, 25 different vaccinations, different boosters shot protocols, and varying treatments have clouded the impact of the new variant.

Several studies out of South Africa and the UK indicated people have a 30% to 90% lower chance of being hospitalized due to Omicron versus Delta. However, data out of both nations have shown once a patient is hospitalized, the progression of an Omicron infection is the same as the Delta variant. Researchers aren’t sure if the lower rate is caused by Omicron being milder or if prior infections and vaccinations are blunting the severity among those who get sick.

Researchers in the UK are watching the United States closely to better understand the severity of Omicron. Due to the strength of the antivaccination movement fueled by COVID disinformation, the United States has a statistically significant population that is not only unvaccinated but who will not seek out hospital treatment until they are critically ill.

In Gauteng Province in South Africa, Omicron has peaked in alignment with a forecast prepared by the South Africa Department of Health at the start of the month. South African officials have reported almost 400 deaths in the last week, and Gauteng is still caring for over 3,500 COVID patients.

Another factor that will make tracking the progress harder is the holiday break between Dec 24. and Jan 3. There are fewer tests that happen over weekends and many testing centers will be closed on Christmas and New Year’s Day. The WSDoH won’t report data from Dec. 24 through Dec. 26, and it will take a couple of days for test results to catch up. The same phenomenon will occur from Dec. 31 through Jan. 2. Some may misinterpret the lower number of tests as proof that Omicron won’t have a major impact.

Doctors lost a critical tool in reducing hospitalizations during the Delta wave today, as the FDA paused the distribution of monoclonal antibodies from Regeneron and Lilly. The cocktail that was administered intravenously, was up to 70% effective in preventing hospitalizations but has been rendered useless by the Omicron variant. Sotromivab is the remaining effective monoclonal antibody but is not manufactured in the United States so supplies are tight. The U.S. Department of Health and Human Services distributed 55,000 doses this week nationally, with Washington getting 552. Another 300,000 doses will be ready in January.

On Wednesday the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) to the antiviral drug Paxlovid, made by Pfizer. Paxlovid was shown to reduce hospitalizations and death by as much as 89% in phase three testing. The medical is a pill that can be taken at home, eliminating the need for injection clinics and putting high-risk COVID patients together for treatment. The first 265,000 doses will be distributed nationally in January. HHS has not released information on state allocations. With national COVID cases forecasted to be as high as 2.8 million per day by the end of next month, it will be a drop in a bucket filled with COVID.

The FDA also granted EUA for the Merck antiviral, molnupiravir. Developed to treat diseases a range of viruses such as influenza and Ebola, Merck reported phase three testing found the oral medical was 50% effective at preventing COVID hospitalizations. Millions of doses of the drug have already been staged across the United States in anticipation of its approval.

In November the FDA reluctantly voted to approve the drug in a 13-10 vote. After reviewing the data provided by Merck, effectiveness was projected to be 30%. Ultimately, despite the lower success rate, the advisory committee decided that the benefits outweighed the risks.

All three medications are meant to be administered to people who are at high risk for severe disease due to comorbidities such as having a compromised immune system. Some states such as Florida have stated they will ignore FDA guidelines despite the short supplies and will distribute the medications on a first-come, first-served basis.

The UK and France reported a record number of new cases today while in the United States, new COVID case counts exceed the peak set during the Delta wave. The IHME in Seattle predicts that between Jan. 1 and Mar. 1 there will be 140 million COVID cases in the United States. The same forecast estimates that Washington could experience 28,000 to 40,000 new cases a day toward the end of January.

On Dec. 22, Dr. Anthony Fauci said that large gatherings over the holiday would not be safe, even with booster shots and masks.

“There are many of these parties that have 30, 40, 50 people in which you do not know the vaccination status of individuals. Those are the kind of functions in the context of Omicron that you do not want to go to,” Fauci said during a White House briefing.

On the same day Fauci recommended skipping large gatherings, the TSA screened 2.1 million airline passengers. That was almost double the number of people from 2020 and 150,000 more people than 2019 B.C. – Before COVID.

Breaking News, Health and Lifestyle, Local, National

Where London goes with Omicron Seattle will follow, with the rest of the US close behind

[KIRKLAND, Wash.] – (MTN) A record 93,000 new COVID cases were reported in the United Kingdom by the National Health Service just hours after Trevor Bedford, Ph.D., an Associate Professor, Biostatistics, Bioinformatics and Epidemiology Program Vaccine and Infectious Disease Division, at Fred Hutchinson Cancer Research indicated that where London goes, Seattle will follow five days later.

France closed its borders to the UK on Friday evening and on Saturday, London Mayor Sadiq Khan declared a “major incident” as Covid-19 hospital admissions rose 30% in a week. The National Health Service reported seven people have died from the Omicron variant and believe that “hundreds of thousands” of cases are going unreported. Cases are expected to grow at a dizzying rate well into January.

On Friday, Bedford told reporters that 50 percent of new Covid-19 cases in King County, were likely Omicron and doubling every 2.4 days. The next day, Pavitra Roychoudhury, MSc, Ph.D., of the University of Washington Virology Division tweeted that Omicron was 50 percent of all cases in Washington.

In an interview published on Saturday in the New York Intelligencer, Bedford shared his prediction on what is to come. “I can expect caseloads that are huge. I can easily expect a 50 percent attack rate from Omicron. I can easily expect that.”

“Attack rate,” is how much of the population will be infected – and Bedford predicts that half of the United States population will catch the Omicron variant. Because the United States does not take a national approach to genomic sequencing, and not all hospitals test patients for COVID at admission, the number of people already hospitalized is murky. From the earliest reports, the hospitalization rate was between 2% to 5%.

There was little good news to be found over the weekend on the impact the new wave is going to have on the United States. In the Northeast, Mid-Atlantic, and Great Lakes Region hospitals are already at or over capacity and receiving additional aid from FEMA. Many states are struggling with dwindling testing funds and a lack of data because tracking systems were dismantled over the summer.

A cascade of drug makers indicated late in the week that the current version of monoclonal antibodies in distribution aren’t effective against the Omicron variant. Unlike vaccines, which target all antibodies, monoclonal antibodies only target one. The antibody that was “cloned” in the process was effective against previous variants but doesn’t produce a significant immune response with Omicron.

In a series of studies, only Sotrovimab, produced by GlaxoSmithKline, showed promise against the fast-spreading variant. The monoclonal antibody received Emergency Use Authorization ( EUA) from the U.S. Food and Drug Administration (FDA) on May 26. Health and Human Services (HHS) reported they would be distributing 55,000 doses across the United States this week, with Washington receiving 552.

Back in the UK, the National Health Service reported that on any given day, about one percent of the national health force would be absent from work due to illness. In London, the number of workers calling out sick surged 40 percent. In the United States, healthcare workers have been fleeing the profession for years, while nurses have complained about short staffing for over a decade. Area hospitals will be impacted dramatically if Omicron starts to infect their workforces.

HHS reported over 68,000 people were hospitalized with COVID across the United States. Statewide on Friday, only eight percent of acute care and 12 percent of ICU beds were available. In King County many hospitals are already at or above capacity, but not due to COVID patients. A shortage of staffed skilled nursing and rehabilitation beds has left patients ready for discharge nowhere to go.

Over the summer when patient loads were lower, the Delta wave brought Oregon and Washington hospitals to the brink of crisis standards of care while collapsing the healthcare systems in Idaho and Alaska. Hospitalization rates for COVID and non-COVID patients are already much higher as the region prepares to face the biggest challenge yet.

According to HHS, EvergreenHealth Kirkland had 19 acute care beds available while Overlake had 17. Both hospitals were reporting ICUs near capacity with 3 beds at Evergreen and 4 at Overlake.

During the Delta surge, states learned that activating the National Guard for nurses and doctors was a poor option. Trained hospital staff who are “weekend warriors” were frequently already supporting surging hospital admissions. The activation in some cases made staffing situations worse.

King County residents vented their frustration on social media about the inability to get a booster shot, find home COVID antigen tests, and PCR test results being delayed. In other circles, Seahawks fans raged against the scheduling change against the Rams due to coronavirus.

Officials in the UK pleaded with government officials to implement further public health restrictions to stem the tide of new cases, as models indicate that by January, the island nation could see 3,000 to 4,000 new hospitalizations a day. Londoners were already starting to deal with closed shops and restaurants, and delays in services because so many people have been sickened.

It is unlikely any additional restrictions will be implemented across the United States, where COVID has been turned into a political weapon. The U.S. Department of Homeland Security (DHS) indicated in a Nov. 10 memo, “If a new COVID-19 variant emerges and new public health restrictions are imposed as a result, anti-government violent extremists could potentially use the new restrictions as a rationale to target government or public health officials or facilities.“

Numerous studies and growing real-world data from Africa and Europe indicate that immunity from prior COVID infections or vaccination without a booster provides enough protection to prevent severe COVID symptoms that result in hospitalization and death. Booster shots ideally received within the previous 12 weeks, boost immunity for more.

For people relying on viral vector vaccines such as Johnson & Johnson, AstraZeneca, or Russia’s GNCEM, there appears to be even less protection without a booster. On Thursday, The Centers for Disease Control (CDC) endorsed the recommendation from the Advisory Committee on Immunization Practices (ACIP) to recommend the mRNA Pfizer and Moderna vaccines over Johnson and Johnson. The decision was made due to the waning effectiveness of the J&J vax and nine confirmed fatalities, seven women including one from Seattle, and two men, from vaccine-induced immune thrombotic thrombocytopenia (VITT).

A study published on Dec. 14 found that Moderna with a booster provided the best protection from Omicron, followed by Pfizer with a booster, and then Johnson & Johnson with a Moderna booster. The study also evaluated individuals who had a previous COVID infection and then got vaccinated. They found that immunity was better than vaccination without a booster, but not as robust.

Real-world data from Europe and Africa indicate that relying on immunity from a previous COVID infection is offering little protection from becoming symptomatic. Epidemiologists have stated it is possible to be infected with the Delta and Omicron variants at the same time. It also appears that natural immunity from Omicron won’t protect a person from a later Delta infection.

There is mounting evidence that Omicron is no more severe than Delta, but little evidence it is less so. On Friday the Imperial College of London released a report that found no evidence that Omicron is “mild.”

“The study finds no evidence of Omicron having lower severity than Delta, judged by either the proportion of people testing positive who report symptoms or by the proportion of cases seeking hospital care after infection. However, hospitalisation data remains very limited at this time.”

The challenge for the public and health experts is comparing the current global wave to previous spikes in COVID cases. During the original wave in the spring of 2020, no one had any type of immunity. When the Alpha and Beta waves came in the winter of 2020, vaccines were just rolling out. When Delta arrived the variant was more transmissible and more severe than prior strains. It also was capable of nibbling around the edges of vaccine protection due to its mutations.

Omicron has arrived in a population that has received a variety of mRNA and viral-vector vaccines with different doses as well as disease acquired immunity from different strains. The timing of receiving a vaccine, prior infection, or a combination also impacts how much immunity a person has.

Many people are more mobile and have returned to work and school while simultaneously taking fewer precautions. An additional challenge is the rate of vaccination is not homogenous, with highly vaccinated communities adjacent to vaccine-resistant populations.

All of these factors are obscuring the true nature of Omicron and because the United States does a poor job of genomic sequencing in some states, little is known about the current hospitalized population and which variant patients have.

Although data out of South Africa has been more encouraging, experts had warned that the recent end of the Delta wave, a higher than understood vaccination rate, and the youthful nature of the South Africa population would favor better outcomes. Although only 26% of South Africa’s total population is vaccinated, over 34% of the county was ineligible due to age. On Oct. 20, the nation expanded vaccination to 12 to 17-year-olds and introduced booster shots to adults on Dec. 9. In reality, 44% of South African adults are fully vaccinated, including 61 percent of people over 50. Additionally, only 5.7% of South African residents are 60 or older.

Researchers are watching King County closely for several reasons. The region is a leader in genomic sequencing and research. As Omicron moves through the region it will provide critical data to build a better understanding of transmissibility, the impact on public health measures, prevention and treatment, and how severe Omicron is. King County is highly vaccinated, but has pockets of low vaccine acceptance, providing a more realistic cross-section. Finally, New York City is almost unique compared to other US cities due to its size, reliance on public transit, and the number of people who live in buildings with communal areas.

Dr. Cameron Webb, the senior policy advisor for equity for the White House COVID Response Team shared early symptoms to look for if you start feeling ill.

  • Sore throat, espeically if it is more than mild
  • Headache
  • Fatigue – severe fatigue appears more common in children
  • Runny nose
  • Sneezing
  • Dry cough

County health officials continue to appeal for people to get vaccinated and get a booster shot if they are eligible. They recommend frequent hand washing and wearing an N-95, KN-94, or KN95 mask whenever you’re out of your home, and to stop using cloth masks. When it comes to Christmas and New Year’s celebrations and travel plans, it is recommended to test the day off and celebrate outside or in well-ventilated indoor areas.

Because of the systems put in place by King County Public Health and supported by County Executive Dow Constantine, the region is better prepared to provide vital data to the rest of the nation. It is very likely that by Christmas, Seattle will feel a lot more like March 2020 than December 2021.

Breaking News, Health and Lifestyle, Local, National

BREAKING: King County residents are urged to prepare for the largest COVID wave to date

[SEATTLE, Wash.] – (MTN) A forecast created by Trevor Bedford, Ph.D., an Associate Professor, Biostatistics, Bioinformatics and Epidemiology Program Vaccine and Infectious Disease Division, at Fred Hutchinson Cancer Research Center, projects that King County will reach record levels by Dec. 22.

In a press conference on Friday, Dr. Jeffrey Duchin, Health Officer, Public Health Seattle & King County said, “The Omicron outbreak we’ve been talking about is no longer theoretical. It is real and it’s here.”

Dr. Duchin shared the current situation in King County, adding that UW Medicine is finding 40% of tests are positive for Omicron and new COVID cases are up 50% since Thanksgiving.

Dr. Santiago Neme, MD, MPH of UW Medicine expressed concern over the number of patients already in Washington hospitals. “Our numbers for COVID infected patients have decreased,” Dr. Neme, said, “but we have been operating at a full or over full capacity for several months in many areas of the state.”

“Any increase in hospital rates or utilization will be pretty challenging for us and very concerning.”

Dr. Duchin added that In King County, hospitals are already caring for twice as many patients as before the start of the Delta wave in August.

Bedford told reporters that the Seattle-Bellevue area would be one of the first cities in the United States to experience widespread Omicron infections and the area was only “a few days” behind London. “New York City is ahead of Seattle and Rhode Island is as well,” he said. But he added this may be due to Seattle having “great S gene drop out data.” S Gene Target Failure (SGTF) is a faster way to identify a likely Omicron variant infection from a positive COVID test. Genomic sequencing is required to make an absolute determination.

Dr. Alexander L. Greninger M.D., Ph.D., M.S., M.Phil., assistant director of the UW Medicine Clinical Virology Laboratory told reporters that sequencing has a 5 to 7 day lag time.

“The number of samples coming into the labs are as high as we’ve seen during the pandemic, yesterday and the day before,” Dr. Greninger added. The UW Medicine Virology Lab has sequenced about 100 samples, and “98 or 99” were positive for Omicron.

The model was created using genomic sequencing data of positive COVID tests, and information on transmission rates from other countries such as the United Kingdom and South Africa. Bedford estimated Omicron cases were doubling in King County every 2.2 days, which is supported by reports from the University of Washington Department of Virology. If the forecast is accurate there could be 2,100 Omicron cases on top of 500 Delta cases in King County by Wednesday. That would far exceed the record number of daily new cases during the fifth wave, and the doubling would continue every one to three days into January.

“Omicron is an airborne disease like Delta and spreads easier indoors, and is a lot more contagious,” Dr. Duchin said, adding, “We do not yet have a clear picture on severity.”

To prepare for the coming wave the message was clear, “The single most important thing you can do is to get vaccinated and boosted even if you’ve had a prior infection,” said Dr. Duchin, “but vaccination alone won’t stop the spread of Omicron.”

King County Health said we need to take advantage of as many layers of protection as we can. That includes wearing tight-fitting N-95, KN-95, or KN-94 masks indoors. The public should avoid crowded indoor spaces, especially if people are unmasked and there is poor air circulation. If anyone feels sick, they should get tested for COVID and stay home to help blunt the spread.

“If you do gather please do safely as possible,” Dr. Duchin appealed. “Limit the number and size of gatherings. Avoid crowded indoor spaces. Do a rapid test on the day of the gathering. Gatherings will be better in large outdoor places or indoor with open windows and doors.”

Dr. Duchin also recommends avoiding travel, especially to areas with high COVID transmission rates. He added that King County has not closed the door on further public health safety measures, but does not plan to add additional measures beyond the guidelines already in place.

The panel stressed that the severity of illness caused by Omicron is still not known. “My read on severity is still difficult – a large portion of infections are both breakthrough and reinfections,” Bedford told reporters. “It may well be the case that Omicron is intrinsically less severe than Delta, but we don’t know. What matters is how many cases do we get and what fraction of those cases require hospitalizations. That is going to be a very large number of cases, severity is not clear enough to know if it will be very bad, bad, or not so bad.”

When asked about breakthrough cases among the vaccinated, Dr. Greninger said, “Moderna and Pfizer are significantly better than Johnson & Johnson.”

“Serious infection is the most important,” added Dr. Duchin. “Meaningful protection against serious infection, hospitalization, and death will protect many of us in vaccinated communities.”

In King County, 160,000 people 12 and older remain unvaccinated and 250,000 have only had a single dose. According to the Washington State Department of Health, about one-third of fully vaccinated King County residents have received a booster dose.

Public and private employers were urged to start contingency planning now to prepare for staffing shortages. “We need to prepare for a large wave of people becoming ill quickly together,” added Dr. Duchin. “We will try to get guidance so we can get people back to work as soon as possible but plan for ‘large scale’ absenteeism.

Public testing sites for COVID will remain open through the holiday season except on Christmas and New Year’s Day. When asked what to do if you need a test on Christmas or New Year’s, Dr. Duchin recommended using a home test versus going to a hospital emergency department.

When asked about the rest of the United States, Bedford didn’t provide an optimistic picture. “Expect things to light up across the United States shortly – first in the cities and then rural areas.”

Looking ahead to the future, Bedford shared that the models he created in the fall have changed significantly due to the Omicron variant.

“Omicron makes things ‘significantly worse.’ I’m quite worried in nine months we will have both Omicron and Delta circulating,” adding, “Omicron will not get us out of this.”

Health and Lifestyle, Local, National

Omicron variant 20% of Washington COVID cases

[SEATTLE, Wash.] – (MTN) Pavitra Roychoudhury, MSc, Ph.D., of the University of Washington Virology Division, reported 20% of tests samples submitted for genomic sequencing are positive for the Omicron variant. From Dec. 6 to Dec. 10, Omicron jumped from 1% to 20% of samples tested using an S Gene Target Failure (SGTF) test.

The Washington State Department of Health reported on Dec. 13, 75.3% of residents 12 and older are fully vaccinated. Multiple studies have shown that three months after vaccination, Pfizer, Moderna, and Johnson and Johnson had low neutralizing antibodies against the Omicron variant but enough of a secondary response to prevent severe infections. On Dec. 15, the WSDoH reported 1.48 million people of 3.3 million eligible had received a booster shot. Boosters doses have been shown to increase neutralizing antibodies and add additional protection.

Percent of Total Population Fully VaccinatedPercentage of Vaccinated People with Booster DoseTotal Population in GroupAverage 7-Day New Case Rate
70.00% or above33.67%2,343,25072.1
60.00% to 69.99%30.67%1,669,30093.6
50.00% to 59.99%28.79%3,339,30087.4
40.00% to 49.99%25.62%268,97576.5
32.70% to 39.99%31.51%151,850102.6
7 Day New Covid-19 Cases per 100K average by Vaccination Rate for Total Population, Adjusted for Population by County, Booster percentage is based on totally fully vaccinated, not eligible, Average 7-day New Case Rate <25 normal, =>25 to 99.9 moderate, => 100, high transmission

Statewide, the 7 day moving average for new COVID cases was 84.1, indicating moderate coronavirus transmission across the state. Ferry and Columbia Counties are hot spots, while a surge in new cases in Garfield County was winding down.

On Wednesday, the WSDoH reported four super spreader events on Dec. 4, involving high school wrestling tournaments in Yelm, Puyallup, Sumner, and Lacey. Participants and spectators came from  Clark, Cowlitz, Grays Harbor, King, Kitsap, Lewis, Mason, Skagit, Snohomish, Pierce, Thurston, Whatcom, and Yakima Counties, and one school from Oregon.

Officials reported that 80 to 90 people had confirmed COVID cases so far, and they expect to find more infections. Infections were among vaccinated and unvaccinated individuals, and three genomic sequenced tests were positive for the Omicron variant.

On Tuesday, the U.S. Centers for Disease Control (CDC) presented two potential national scenarios in a closed-door media briefing. The first predicted a continued Delta surge followed by a smaller wave of Omicron cases spiking in the early spring. The second had Delta, Omicron, and Influenza surging simultaneously in January, potentially overwhelming hospitals.

Omicron has world leaders and health officials increasingly worried as cases surge around the globe. Seventy-seven countries and 36 states have confirmed cases.

In South Africa, over 7,300 people are hospitalized, an increase of 81% from a week ago, with cases exploding outside of Gauteng Province. The South Africa Department of Health reported 26,976 positive cases today, and the 7 day moving average jumped to over 23,000 – a new record.

The United Kingdom reported a single-day record for new COVID cases – 78,610. National Health Services leaders said 60% of all cases in London are the Omicron variant and 35% of cases nationwide. British prime minister Boris Johnson told reporters that cases of Omicron are doubling in less than two days.

“I’m afraid we’re also seeing the inevitable increase in hospitalizations up by 10 percent nationally week on week and up by almost a third in London.”

In a political blow, the conservative members of his party voted down stricter measures meant to curb the growing number of hospitalizations.

The European Centre for Disease Prevention and Control Rapid Risk Assessment from Dec. 15 issued a stark warning to the European Union members.

“Although current data on the severity of the infection associated with the Omicron [Variant of Concern] (VOC) remain limited, evidence to date raises concern that the Omicron VOC may be associated with a significant reduction in vaccine effectiveness against SARS-CoV-2 infection,” the report stated.

“Even in the case of lower infection/disease severity with the Omicron VOC, a steep, exponential increase in cases caused by the Omicron VOC will result in a growing number of cases with severe disease. As EU/EEA countries are still facing the severe impact of the Delta VOC wave, a further rise in hospitalisations could quickly overwhelm healthcare systems.”

Many pundits have rushed to declare Omicron as mild relying on abstracts, articles, and soundbites. Many doctors believe the early data is encouraging but caution against rushing to conclusions.

Several publications are quoting an article from the LKS Faculty of Medicine from the University of Hong Kong by Dr. Michael Chan Chi-wai, Associate Professor of School of Public Health and Principal Investigator, and Professor John Nicholls, Professor of Department of Pathology.

The research paper and study data have not been published and currently is under peer review. The article suggested that the Omicron variant can replicate 70 times faster in the lungs’ airways when compared to the Delta variant, creating a higher viral load. Dr. Chan also suggested that Omicron may infect multiciliated cells found in the deep lungs at a slower rate when compared to the Delta variant.

Dr. Chan stressed that COVID infections are complicated, and only looking at the ability to infect lung cells was too narrow to reach a broader conclusion on severity. “It is important to note that the severity of disease in humans is not determined only by virus replication but also by the host immune response to the infection, which may lead to dysregulation of the innate immune system.”

He went on to add, “By infecting many more people, a very infectious virus may cause more severe disease and death even though the virus itself may be less pathogenic. Therefore, taken together with our recent studies showing that the Omicron variant can partially escape immunity from vaccines and past infection, the overall threat from Omicron variant is likely to be very significant.”

.

Breaking News, Health and Lifestyle, Local, National

Omicron variant identified in 13% of recent Washington COVID tests

Editor’s Note: As a policy, Malcontent News does not quote or publish data from pre-print studies. The transmission rate of the Omicron SARS-CoV2 variant is so high it is spreading at a rate faster than the scientific review process. It is for this reason, we are using pre-print studies in our reporting and analysis for the Omicron variant. We will continue to backlink to all quoted sources to support transparency in reporting.

[SEATTLE, Wash.] – (MTN) Pavitra Roychoudhury, MSc, Ph.D., of the University of Washington Virology Division, reported 13% of tests samples submitted for genomic sequencing on Dec. 8 were positive for the Omicron variant. Tentative confirmation was made using an S Gene Target Failure (SGTF) test, with Dr. Roychoudhury indicating in a tweet that it will take a few days for genomic sequencing confirmation.

Using the data provided by the University of Washington, Omicron variant cases in Washington doubled every 24 hours from Dec. 6 to Dec. 8. The total number of new COVID cases being detected indicates that the Omicron variant is rapidly replacing Delta, not adding to confirmed cases at this time.

Nathan Grubaugh, Ph.D., Associate Professor of Epidemiology at the Yale School of Public Health, tweeted researchers were seeing a similar trend among samples collected in Connecticut.

If the rate of new case growth for Omicron continues at the current rate in Washington, it would be the fastest case growth rate observed to date. In South Africa and across the United States, Omicron cases have been doubling every three days. In the United Kingdom, cases have been doubling every two-and-a-half days and in Denmark, every two days.

Sikhulile Moyo, director at the Botswana Harvard AIDS Institute Partnership (BHP) lab in Gaborone and a research associate in immunology and infectious diseases at Harvard T.H. Chan School of Public Health was the first person to sequence the Omicron variant on Nov. 8. He shared his findings on GISAID on Nov 11, which caught the attention of virologists around the world.

Lancet Labs in South Africa started seeing an alarming number of PCR tests from the Gauteng Province missing the target S gene in mid-November. Lancet shared the findings with the Network for Genomics Surveillance in South Africa (NGS-SA), which called an urgent meeting on 23 November. “We were shocked by the number of mutations,” says Tulio de Oliveira in a report in Science, a virologist at the University of KwaZulu-Natal and NGS-SA’s principal investigator.

On Nov. 24, Dr. Alex Sigal of the Africa Health Institute received three test swabs with the Omicron variant and started growing the virus to test it against sera from vaccinated and recovered individuals.

On the same day, Lancet sequenced another 100 samples with the missing S gene, and all were positive for the newly discovered variant. The South Africa Department of Health sent their findings to the World Health Organization (WHO) on Nov. 24, and Omicron was labeled a Variant of Concern (VOC) on Nov. 26.

Despite the first three cases appearing in Botswana, Omicron was likely circulating undetected on several continents by late October. The Centers for Disease Control (CDC) reported last week that the first symptomatic Omicron case in the United States was on Nov. 15. The implementation of international travel restrictions likely had no impact on slowing the spread of the highly infectious variant.

Nevada became the most recent state to report an Omicron variant COVID case on December 14

Preliminary data has emerged over the last week on transmissibility, treatment efficacy, and vaccine effectiveness for Omicron.

A study out of South Africa published on Dec. 2, found that Omicron was 2.5 to 3.5 times more transmissible than Delta. The study, which has not been peer-reviewed, indicated the Rt, a measure of how quickly a communicable disease can spread, is between R12 and R17, which is comparative to measles. On Dec. 8, Hiroshi Nishiura, professor at Kyoto University released a study that found Omicron is 4.2 times more transmissible than Delta with an Rt of R20. If additional research were to find this true, the Omicron COVID variant would be the most transmissible disease observed in the modern medicine era.

Omicron is forecasted to become the dominant strain in the United Kingdom and Denmark this week and was already 44% of detected COVID cases in the UK on Tuesday. The CDC reported tonight Omicron represents 3% of all detected COVID cases in the United States.

Eleven studies and reports, none of which have been peer-reviewed, have been published on vaccine effectiveness in the last 10 days. Studies have evaluated the Pfizer, Moderna, Johnson and Johnson, and AstraZeneca vaccines.

Studies that reviewed the effectiveness of the Pfizer vaccine found that the effectiveness of preventing symptomatic illness dropped from 80% to zero to 35%, depending on the study. Very limited real-world data out of South Africa from Discovery Health released today showed that the Pfizer vaccine was only 33% effective at preventing infection.

The same study found that the Pfizer vaccine was 70% effective at preventing “severe complications of Covid-19,” down from 93% with the Delta variant.

Dr. Peter English, Retired Consultant in Communicable Disease Control, Former Editor of Vaccines in Practice, past Chair of the BMA Public Health Medicine Committee had this to say about the findings.

“Two doses of vaccine are 70% effective at preventing hospitalization. They are not ineffective, but they are much less effective than the 90-95% protection that two doses provided against hospitalization. With a highly infectious variant, this still risks a catastrophic number of hospitalizations.”

A non-peer-reviewed study published on Tuesday evening provided the first data on the effectiveness of the Moderna vaccine, and more data for the Johnson & Johnson/Jassen vaccine.

Researchers evaluated the sera from 239 vaccinated healthcare workers in the Boston area. The study found that for the Moderna and Pfizer vaccine, more than 50% of individuals had no neutralizing antibodies three months after vaccination. The Moderna vaccine showed a 43-fold decrease in antibodies while the Pfizer vaccine had a 122-fold decrease. The Johnson and Johnson vaccine performed better against the Omicron variant versus Delta but had significantly reduced effectiveness versus the original COVID strain.

For individuals who had a prior Covid-19 infection and then got vaccinated more than six months ago, the Moderna vaccine had a 9-fold decrease in neutralizing antibodies, the Pfizer vaccine had a 12-fold decrease, and the Johnson & Johnson vaccine had a 17-fold decrease.

The study also found an mRNA booster within the last three months provided a significant increase in neutralizing antibodies but did not provide the same level of protection versus the Delta variant. The samples from the Johnson and Johnson test subjects were all boosted with a half-dose of the Moderna vaccine.

Two studies on disease acquired immunity found that protection declined significantly compared to previous variants. A study published on Dec. 2 out of South Africa, which has not been peer-reviewed, found that protection against Omicron dropped 240% for individuals who were previously infected by the original strain, Beta, or Delta, and had never been vaccinated. Another study released on Dec. 9 reached a similar conclusion, and in an alarming find, reported up to 40% of individuals who had a previous Delta infection were experiencing reinfection with Omicron. The Delta wave ended on Sep. 19 in South Africa, suggesting it took less than three months for protection to wane.

Scientists, public health officials, and policymakers have been attempting to determine if Omicron is less severe than the Delta variant. The study released from Discovery Health today reported that Omicron was 29% less severe than the original COVID strain.

“Without seeing a preprint or the report on which this press release is based it is difficult to get a clear understanding of the validity of these conclusions,” said Prof. Paul Hunter, Professor in Medicine at the University of East Anglia and a member of the National Institute of Health Research in the U.K. “If these are valid conclusions then there are both reassuring and worrying findings.  The report that reinfections are more common with Omicron has already been published and the evidence is strong that Omicron can increase the risk of infection in people who have already had a COVID infection.”

Other experts warned against reading too much into the Discovery Health report.

Dr. Simon Clarke, Associate Professor in Cellular Microbiology, University of Reading, said, “This press release outlines preliminary observations of Covid-19 in South Africa during the first three weeks of the wave of infections caused by the Omicron.  It shouldn’t be forgotten that in the UK, during the initial epidemic there was a 5-week gap between the first diagnosis and the first death.  A situation report taken in those first few weeks would not have given us an accurate picture of what was about to happen, so we shouldn’t expect these preliminary indications to be a portent of how the Omicron epidemic will play out here.”

The Centers for Disease Control (CDC) provided detailed information on Dec. 10 about the first 43 Omicron variant cases detected in the United States. The report found that one person required hospitalization and was released after two days. Almost 60% were 39 years old or younger and 33% had recently traveled internationally. Forty of the 43 cases were vaccinated or had a previous COVID infection. Among the 34 who were vaccinated, 14 had received a booster.

Officials believe the high infection rate for vaccinated individuals has created a data fallacy. International travelers are more likely to be vaccinated, younger, and healthier and many were not eligible for a booster.

The Washington State Department of Health (WSDoH) reported 75.3% of all Washingtonians 12 and older are fully vaccinated and almost one in four children five to eleven have received their first dose of the Pfizer COVID vaccine. An estimated 3.5 million residents are eligible for boosters, but only 1.35 million have received one to date.

WSDoH reported the 7 day moving average for new cases is 1,333, and the statewide 7 day moving average new case rate is 83.5 per 100K residents – moderate transmission. The state has been averaging 650 to 700 hospitalized COVID patients a day, with roughly 100 requiring ventilators.

Statewide new admissions for COVID-related illness started increasing on Nov. 27, and through Dec 7. was averaging 92 new admissions a day. On Tuesday there were approximately 642 available staffed acute care and 144 staffed ICU beds throughout Washington.

Health and Lifestyle, Local

BREAKING: 3 lab-confirmed Omicron variant COVID cases in Washington

[OLYMPIA, Wash.] – (MTN) The Washington State Department of Health (WSDoH), in partnership with the UW Medicine Virology Laboratory, has confirmed a total of three cases of omicron variant in Thurston County, Pierce County, and King County. The patients range in age from 20 to 39, two men, one woman.

The patients are:

  • a man in his thirties from Thurston County,
  • a man in his twenties from Pierce County, and
  • a woman in her twenties from King County.

Confirmation came in midday Saturday, and officials were still in the process of notifying the patients.

The WSDoH did not have information on their condition, travel history, or vaccination status. The samples were collected using PCR tests between Nov. 29 and Dec. 1 and were submitted for genomic sequencing.

Sequencing has been prioritized for anyone with travel history or close contact with a confirmed case.

“We knew that it was a matter of time before omicron was sequenced in our state and so we were anticipating this very news,” said Umair A. Shah, MD, MPH, Secretary of Health. “We strongly urge people to get vaccinated and get their boosters as soon as possible to maximize their level of protection from any variant.”

“Even with a highly mutated virus-like omicron, we are not going back to square one of the pandemic,” said Dr. Jeff Duchin, Health Officer, Public Health – Seattle & King County. “Omicron may pose new challenges that we will need to respond to, but compared to the early days of the pandemic, we know much more about COVID-19, and we’re better prepared for it. We know layered protections work together to maximally reduce risk, and that will continue to be the case for delta and for omicron if that becomes a dominant strain circulating in our community.”

“We suspected that the omicron variant was circulating in our region, and now our laboratory has confirmed the first three cases in Washington state by viral genome sequencing in the last 24 hours. Throughout the pandemic, it’s been a huge team effort by the UW Medicine Virology Laboratory, requiring development and implementation of several diagnostic and sequencing assays to detect and confirm the variety of COVID-19 variants that have surfaced in Washington state,” said Dr. Geoffrey Baird, chair of Laboratory Medicine and Pathology at UW School of Medicine. To date, the laboratory has tested approximately 3.8 million COVID-19 samples.

A study about the transmissibility of the omicron variant was released from a multinational group of researchers on Friday. The study, which has not been peer-reviewed, indicated that omicron is two times to three times more transmissible than the prevalent delta variant. Researchers estimate that the Rt, called, “r-naught,” is R12 to R17, which is equivalent to measles. The Rt for delta is R6.0 and for the AY.4.2 delta variant is R6.6.

Another study released on Thursday indicated that people relying on disease acquired immunity are up to 240% more likely to be infected from the omicron variant versus the beta or delta variants.

The CEOs of Pfizer and Moderna stated their vaccines would remain highly effective at preventing severe COVID and hospitalizations. Researchers are still one to two weeks away from preliminary information on if there will be significant vaccine escape with the omicron variant.

Public health officials are recommended for the unvaccinated to get vaccinated and for the 2.2 million Washingtonians eligible for a booster to get one. Washington state continues to have an indoor mask mandate.

Individuals who are experiencing COVID-like symptoms or have a known close contact should get tested. If you have traveled or know you had close contact with a traveler and get a positive test result from a home test, you should follow up with a PCR test to aid in tracking the spread of the omicron COVID variant.